Special Populations Immunization

Immunization in special populations addresses groups whose immune status, life stage, or exposure changes the benefits, risks, or response to vaccines, including pregnant people, immunocompromised individuals, older adults, and travellers. For these groups the general principles of immunization are adapted to balance protection against particular safety and effectiveness considerations.

Definition

Special-populations immunization is the application and adaptation of vaccination to groups in whom immune status (for example immunocompromise), physiological state (for example pregnancy or older age), or exposure (for example travel) alters the benefit-risk balance, the choice of vaccine, or the expected immune response.

Scope

This entry explains the conceptual considerations that distinguish immunization in special populations: how altered immunity changes vaccine response and the role of live versus non-live vaccines, how maternal immunization protects both mother and infant, and how indirect protection of vulnerable contacts matters. It is an educational overview; the specific vaccines, timing, and precautions for any individual in these groups are governed by current recommendations and clinical judgement and are not reproduced here.

Core questions

• How does altered immunity change the safety and effectiveness of vaccines, and why do live vaccines need particular consideration?
• How does maternal immunization protect both the pregnant person and the newborn?
• Why may older adults respond less robustly to some vaccines, and what does that imply for protection?
• How does protecting close contacts (cocooning) and the wider community help shield those who cannot be vaccinated?
• What additional exposures make travellers a distinct group for immunization considerations?

Key concepts

• Immunocompromise and live-vaccine considerations
• Maternal (transplacental) antibody transfer
• Maternal immunization
• Immunosenescence and reduced response in older adults
• Blunted immunogenicity and altered correlates of protection
• Cocooning of vulnerable contacts
• Travel-related exposure
• Benefit-risk individualization

Mechanisms

In special populations the same immunization principles are adjusted to altered biology. In immunocompromise the response to vaccines may be blunted and live vaccines can pose particular risks, so platform choice and timing are weighed carefully (Rubin, 2014). In pregnancy, vaccinating the mother both protects her and transfers antibody across the placenta to protect the infant in early life, as shown for influenza (Zaman, 2008). With ageing, immunosenescence can reduce the magnitude and durability of responses, affecting the correlates of protection achieved (Plotkin, 2010). Where direct vaccination is limited, indirect protection through immunising close contacts and maintaining community immunity helps shield the vulnerable (Fine, 2011).

Clinical relevance

Tailoring immunization to pregnant people, immunocompromised patients, older adults, and travellers is a routine part of preventive care across primary care, obstetrics, specialty and travel medicine. This entry describes the considerations that make these groups distinct; the specific vaccines, timing, and precautions appropriate for an individual are set by current authoritative recommendations and the clinician and are not specified here.

Epidemiology

Special populations often bear disproportionate burden from vaccine-preventable disease: immunocompromised people are at higher risk of severe infection, infants too young to be vaccinated benefit from maternal immunization, and older adults experience greater severity from several vaccine-preventable infections (Rubin, 2014; Zaman, 2008). Because some of these groups respond less well or cannot receive certain vaccines, community immunity and protection of contacts are especially important for them (Fine, 2011).

History

Recognition that immunization must be adapted for special populations grew alongside expanding vaccine availability, the care of immunocompromised patients, and evidence that maternal immunization protects infants. Dedicated guidance for vaccinating the immunocompromised host and randomized evidence on maternal influenza immunization consolidated this distinct field of practice (Rubin, 2014; Zaman, 2008).

Key figures

• Lorry G. Rubin
• Mark C. Steinhoff
• Stanley A. Plotkin
• Paul Fine

Seminal works

• rubin-2014
• zaman-2008

Frequently asked questions

Why does immunization need special consideration in immunocompromised people?

Their immune response to vaccines may be weaker, and certain live vaccines can pose particular risks, so the choice of vaccine and its timing are weighed carefully. The specifics for an individual are governed by current recommendations and the clinician (Rubin, 2014).

How does vaccinating during pregnancy help the baby?

Maternal immunization can protect the pregnant person and transfer protective antibody across the placenta, helping shield the newborn during the early months before the infant can be vaccinated, as demonstrated for influenza (Zaman, 2008).